Increasing evidence suggests that interplays between Wnt/β-catenin and PI3K/AKT signaling cascades are involved in tumor development and progression. However, the exact mechanism in glioma is not well known. Using aspirin, we found that the expression levels of AKT1 in glioma cells significantly correlated with the transcriptional activity of β-catenin. Similar observations were made when we subjected glioma cells to treatment with Tcf4 siRNA. Moreover, both aspirin and Tcf4 siRNA can suppress the proliferation and induce apoptosis of glioma. In addition, our analysis of the gene promoter of AKT1 revealed multiple putative Tcf-4 binding sites. In support of the concept that β-catenin/Tcf-4 is a transcriptional regulator for AKT1, results from our chromatin immunoprecipitation studies and luciferase assay showed that β-catenin/Tcf-4 binds to the potential binding sites in the gene promoter of AKT1. Furthermore, using immunohistochemistry, we found that Tcf-4 protein expression increased significantly in high-grade glioma in comparison to low-grade glioma and correlated with AKT1 expression. In conclusion, our results support the concept that β-catenin/Tcf-4 directly regulates AKT1 in glioma, and these two proteins may cooperate with each other in exerting their oncogenic effects in glioma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3892/ijo.2011.1104 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of Nuclear Peripheral Chromatin Lamin LMNB1 Gene in the Proliferation and Migration of Glioma Cells.
Neurochem Res
December 2024
The Pathology Department of Shanxi Provincial People's Hospital, Taiyuan, 030012, China.
The goal of this study is to explore the role of the LMNB1 gene in glioma. A cohort of 160 patients who underwent glioma surgery were randomly selected of this study. The LMNB1 expression was assessed employing immunohistochemical and real-time quantitative polymerase chain reaction methods.
View Article and Find Full Text PDFSynergistic antitumor effects of Phlorizin and Temozolomide in glioblastoma: Mechanistic insights and molecular targeting.
Fitoterapia
January 2025
College of Life Science, North China University of Science and Technology, Tangshan, Hebei 063202, PR China; School of Public Health, North China University of Science and Technology, Tangshan, Hebei 063202, PR China. Electronic address:
Article Synopsis
- * This study examines the effects of phlorizin, a natural compound, both alone and with the standard chemotherapy drug temozolomide (TMZ), finding that phlorizin significantly reduces cell growth and migration, especially when paired with TMZ.
- * Research indicates that phlorizin targets the PI3K/AKT/mTOR signaling pathway, which is vital for GBM cell survival, suggesting that phlorizin combined with TMZ could be a promising new treatment approach for this aggressive cancer.*
Role of scaffold proteins in the heterogeneity of glioblastoma.
Cell Commun Signal
October 2024
Department of Medicine, Division of Hematology and Oncology, College of Medicine and Life Sciences, Health Sciences Campus, The University of Toledo, 352A Health Science Building, 3000 Transverse Drive, Toledo, OH, 43614, USA.
Glioblastoma (GB) is a highly heterogeneous type of incurable brain cancer with a low survival rate. Intensive ongoing research has identified several potential targets; however, GB is marred by the activation of multiple pathways, and thus common targets are highly sought. The signal regulatory scaffold IQGAP1 is an oncoprotein implicated in GB.
View Article and Find Full Text PDFEndosome-microautophagy targeting chimera (eMIATAC) for targeted proteins degradation and enhance CAR-T cell anti-tumor therapy.
Theranostics
August 2024
Department of Neurosurgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P. R. China.
Since oncogene expression products often exhibit upregulation or abnormally activated activity, developing a technique to regulate abnormal protein levels represent a viable approach for treating tumors and protein abnormality-related diseases. We first screened out eMIATAC components with high targeted degradation efficiency and explored the mechanism by which eMIATAC induced target protein degradation, and verified the degradation efficiency of the target protein by protein imprinting and flow cytometry. Next, we recombined eMIATAC with some controllable elements to verify the regulatable degradation performance of the target protein.
View Article and Find Full Text PDFIntegrated network pharmacology and experimental verification to reveal the role of Shezhi Huangling Decoction against glioma by inactivating PI3K/Akt-HIF1A axis.
Heliyon
July 2024
Department of Neurosurgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Article Synopsis
- * Analysis of SHD identified 461 active constituents and revealed that it influences various cancer-related pathways and hub genes, potentially affecting glioma characteristics like migration and apoptosis.
- * SHD was found to enhance the effectiveness of temozolomide (TMZ) in restricting tumor growth, indicating its potential as a complementary therapy for glioblastoma.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!